Exothera
Olivier Dezutter is a Business Development Manager at EXOTHERA since November 2020, and previously served as a Business Developer. Olivier gained experience in the Unilever Future Leaders Programme in Customer Development from September 2019 to November 2020, where there was a focus on exploring the company and developing management skills. Prior to that, Olivier completed a consultancy project at Baxter International Inc. in mid-2019, addressing Outpatient Parenteral Antimicrobial Therapy reimbursement. Olivier's early career includes an internship and role as a pharmacist at apotheek beke debusschere from July 2017 to August 2018, emphasizing pharmaceutical compounding and medication counseling. Academic qualifications include a Master's degree in Pharmaceutical Care from Ghent University and a Master in General Management from Vlerick Business School.
Exothera
Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing. Company number: 0744643660 VAT: BE0744643660